D J Paul E Cowan Net Worth

The estimated Net Worth of D J Paul E Cowan is at least $3.12 Milion dollars as of 16 October 2017. D Cowan owns over 100,000 units of Quotient Ltd stock worth over $1,200,233 and over the last 10 years D sold QTNT stock worth over $1,922,771.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

D Cowan QTNT stock SEC Form 4 insiders trading

D has made over 8 trades of the Quotient Ltd stock since 2015, according to the Form 4 filled with the SEC. Most recently D sold 100,000 units of QTNT stock worth $464,000 on 16 October 2017.

The largest trade D's ever made was selling 100,000 units of Quotient Ltd stock on 16 October 2017 worth over $464,000. On average, D trades about 40,035 units every 73 days since 2015. As of 16 October 2017 D still owns at least 3,158,509 units of Quotient Ltd stock.

You can see the complete history of D Cowan stock trades at the bottom of the page.

What's D Cowan's mailing address?

D's mailing address filed with the SEC is ELIZABETH HOUSE, 9 CASTLE STREET, , ST. HELIER, Y9, JE2 3RT.

Insiders trading at Quotient Ltd

Over the last 11 years, insiders at Quotient Ltd have traded over $5,237,327 worth of Quotient Ltd stock and bought 21,364,813 units worth $72,052,006 . The most active insiders traders include Advisors Llcperceptive Life..., Zubeen Shroff a L John Wilkerson. On average, Quotient Ltd executives and independent directors trade stock every 15 days with the average trade being worth of $57,203. The most recent stock trade was executed by Catherine Larue on 31 January 2023, trading 438 units of QTNT stock currently worth $166.

What does Quotient Ltd do?

Complete history of D Cowan stock trades at Quotient Ltd

Quotient Ltd executives and stock owners

Quotient Ltd executives and other stock owners filed with the SEC include:

• Franz Walt,
  Chief Executive Officer, Director
• Edward Farrell,
  Chief Operating Officer
• Jeremy Stackawitz,
  Chief Commercial Officer
• Peter Buhler,
  Chief Financial Officer
• Heino.N.F.M von Prondzynski,
  Independent Chairman of the Board
• Frederick Hallsworth,
  Independent Director
• Brian McDonough,
  Independent Director
• Zubeen Shroff,
  Independent Director
• John Wilkerson,
  Independent Director
• Catherine Larue,
  Independent Director
• Isabelle Buckle,
  Independent Director
• Ernest Larnach,
  Head - Financial Accounting & Treasury
• Esteban Uriarte,
  Chief Manufacturing Operations Officer
• Mohammad El Khoury,
  Chief Commercial Officer
• Christian Albrich,
  Chief People Officer
• Dr. Christine Ginocchio,
  Chief Scientific & Medical Officer
• Dr. Michael Hausmann,
  Chief Technology Officer
• Vittoria Bonasso,
  Head of Fin., Group Controller & Principal Accounting Officer
• Ali Kiboro,
  Chief Financial Officer
• Manuel O. Mendez,
  CEO & Director
• Ernest Larnach,
  Head of Financial Accounting & Treasury
• Vittoria Bonasso,
  See Remarks
• Roland Boyd,
  See Remarks
• Thomas A Bologna,
  Director
• Sarah A Oconnor,
  Director
• Stephen Unger,
  Chief Financial Officer
• Partners V Lp Galen Partner...,
  
• Deidre Quotient Biodiagnost...,
  
• D J Paul E Cowan,
  See Remarks
• Sophie Bechu,
  Director
• Advisors Llcperceptive Life...,
  
• Christopher J Lindop,
  EVP
• Ali Kiboro,
  Chief Financial Officer
• Manuel O. Mendez,
  Chief Executive Officer
• Khoury Mohammad El,
  Chief Commercial Officer
• Thomas Aebischer,
  Director